
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
E3 ubiquitin ligase ring finger protein 5 protects against hepatic ischemia reperfusion injury by mediating phosphoglycerate mutase family member 5 ubiquitination
Mingjie Ding, Hao‐Ran Fang, Jiakai Zhang, et al.
Hepatology (2021) Vol. 76, Iss. 1, pp. 94-111
Open Access | Times Cited: 37
Mingjie Ding, Hao‐Ran Fang, Jiakai Zhang, et al.
Hepatology (2021) Vol. 76, Iss. 1, pp. 94-111
Open Access | Times Cited: 37
Showing 1-25 of 37 citing articles:
The E3 ubiquitin ligase MARCH2 protects against myocardial ischemia-reperfusion injury through inhibiting pyroptosis via negative regulation of PGAM5/MAVS/NLRP3 axis
Shuolin Liu, Yaguang Bi, Tianting Han, et al.
Cell Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 31
Shuolin Liu, Yaguang Bi, Tianting Han, et al.
Cell Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 31
GRINA alleviates hepatic ischemia‒reperfusion injury-induced apoptosis and ER-phagy by enhancing HRD1-mediated ATF6 ubiquitination
Hongjun Yu, Chaoqun Wang, Baolin Qian, et al.
Journal of Hepatology (2025)
Closed Access | Times Cited: 3
Hongjun Yu, Chaoqun Wang, Baolin Qian, et al.
Journal of Hepatology (2025)
Closed Access | Times Cited: 3
Targeting cell death pathways in intestinal ischemia-reperfusion injury: a comprehensive review
Fei Wang, Huiming Huang, Xuejiao Wei, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 12
Fei Wang, Huiming Huang, Xuejiao Wei, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 12
Disruption of tumor-intrinsic PGAM5 increases anti-PD-1 efficacy through the CCL2 signaling pathway
Xiaoying Wei, Hong Wang, Huiquan Liu, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 1, pp. e009993-e009993
Open Access | Times Cited: 1
Xiaoying Wei, Hong Wang, Huiquan Liu, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 1, pp. e009993-e009993
Open Access | Times Cited: 1
The dual role of PGAM5 in inflammation
Yuxin Qi, Bhavana Rajbanshi, Ruihan Hao, et al.
Experimental & Molecular Medicine (2025)
Open Access | Times Cited: 1
Yuxin Qi, Bhavana Rajbanshi, Ruihan Hao, et al.
Experimental & Molecular Medicine (2025)
Open Access | Times Cited: 1
MAPK Signaling Pathways in Hepatic Ischemia/Reperfusion Injury
Bo Yu, Yalong Zhang, Tianyu Wang, et al.
Journal of Inflammation Research (2023) Vol. Volume 16, pp. 1405-1418
Open Access | Times Cited: 20
Bo Yu, Yalong Zhang, Tianyu Wang, et al.
Journal of Inflammation Research (2023) Vol. Volume 16, pp. 1405-1418
Open Access | Times Cited: 20
USP14 governs CYP2E1 to promote nonalcoholic fatty liver disease through deubiquitination and stabilization of HSP90AA1
Dongqin Wei, Xin Tian, Longbo Zhu, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 8
Open Access | Times Cited: 19
Dongqin Wei, Xin Tian, Longbo Zhu, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 8
Open Access | Times Cited: 19
Current status and perspective on molecular targets and therapeutic intervention strategy in hepatic ischemia-reperfusion injury
Jia Liu, Ranyi Luo, Yinhao Zhang, et al.
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. 4, pp. 585-619
Open Access | Times Cited: 7
Jia Liu, Ranyi Luo, Yinhao Zhang, et al.
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. 4, pp. 585-619
Open Access | Times Cited: 7
Therapeutic potential of ASK1 activators in cancer treatment: Current insights and future directions
Bo Wang, Ying Ma, Yue Zhang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117214-117214
Closed Access | Times Cited: 7
Bo Wang, Ying Ma, Yue Zhang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117214-117214
Closed Access | Times Cited: 7
Histone deacetylase 6 deficiency protects the liver against ischemia/reperfusion injury by activating PI3K /AKT /mTOR signaling
Jie Pan, Q C Yu, Yaodong Song, et al.
The FASEB Journal (2024) Vol. 38, Iss. 4
Closed Access | Times Cited: 4
Jie Pan, Q C Yu, Yaodong Song, et al.
The FASEB Journal (2024) Vol. 38, Iss. 4
Closed Access | Times Cited: 4
Lactobacillus reuteri mitigates hepatic ischemia/reperfusion injury by modulating gut microbiota and metabolism through the Nrf2/HO-1 signaling
Leiyi Zhang, Xiaoxiang Gong, Juan Tan, et al.
Biology Direct (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 4
Leiyi Zhang, Xiaoxiang Gong, Juan Tan, et al.
Biology Direct (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 4
MCC950 as a promising candidate for blocking NLRP3 inflammasome activation: A review of preclinical research and future directions
Yujia Zheng, Xiaolu Zhang, Ziyu Wang, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 11
Closed Access | Times Cited: 4
Yujia Zheng, Xiaolu Zhang, Ziyu Wang, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 11
Closed Access | Times Cited: 4
PGAM5 Modulates Macrophage Polarization, Aggravating Inflammation in COPD via the NF-κB Pathway
Yu Zheng, Yujie Wang, Jia Li, et al.
International Journal of COPD (2025) Vol. Volume 20, pp. 551-564
Open Access
Yu Zheng, Yujie Wang, Jia Li, et al.
International Journal of COPD (2025) Vol. Volume 20, pp. 551-564
Open Access
Lactylation: a promising therapeutic target in ischemia-reperfusion injury management
Feixiang Wang, Guo Mu, Zihang Yu, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Feixiang Wang, Guo Mu, Zihang Yu, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Protein modifications in hepatic ischemia-reperfusion injury: molecular mechanisms and targeted therapy
Xiaohong Zhao, Qinyi Li, Xiaolong Zhu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Xiaohong Zhao, Qinyi Li, Xiaolong Zhu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
A simplified and reproducible ex vivo model of cold and ischemia-reperfusion injury
Lele Zhang, Mingjie Ding, Zhu Ying, et al.
Liver Research (2025)
Open Access
Lele Zhang, Mingjie Ding, Zhu Ying, et al.
Liver Research (2025)
Open Access
Phosphoglycerate mutase 5 aggravates alcoholic liver disease through disrupting VDAC-1-dependent mitochondrial integrity
Tian Xia, Jiachi Yu, Ye Chen, et al.
International Journal of Medical Sciences (2024) Vol. 21, Iss. 4, pp. 755-764
Open Access | Times Cited: 3
Tian Xia, Jiachi Yu, Ye Chen, et al.
International Journal of Medical Sciences (2024) Vol. 21, Iss. 4, pp. 755-764
Open Access | Times Cited: 3
ZIP transporters‐regulated Zn2+ homeostasis: A novel determinant of human diseases
Huimei Liu, Lanfang Li, Ruirui Lu
Journal of Cellular Physiology (2024) Vol. 239, Iss. 5
Closed Access | Times Cited: 3
Huimei Liu, Lanfang Li, Ruirui Lu
Journal of Cellular Physiology (2024) Vol. 239, Iss. 5
Closed Access | Times Cited: 3
New insights into ischemia-reperfusion injury signaling pathways in organ transplantation
Kenneth J. Dery, Jerzy W. Kupiec‐Weglinski
Current Opinion in Organ Transplantation (2022) Vol. 27, Iss. 5, pp. 424-433
Closed Access | Times Cited: 15
Kenneth J. Dery, Jerzy W. Kupiec‐Weglinski
Current Opinion in Organ Transplantation (2022) Vol. 27, Iss. 5, pp. 424-433
Closed Access | Times Cited: 15
Pectolinarigenin attenuates hepatic ischemia/reperfusion injury via activation of the PI3K/AKT/Nrf2 signaling pathway
Hao Li, Yabin Chen, Mingjie Ding, et al.
Chemico-Biological Interactions (2023) Vol. 386, pp. 110763-110763
Closed Access | Times Cited: 7
Hao Li, Yabin Chen, Mingjie Ding, et al.
Chemico-Biological Interactions (2023) Vol. 386, pp. 110763-110763
Closed Access | Times Cited: 7
6-Gingerol attenuates hepatic ischemia/reperfusion injury through regulating MKP5-mediated P38/JNK pathway
Qiwen Yu, Jiye Li, Mengwei Cui, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Qiwen Yu, Jiye Li, Mengwei Cui, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Physiological and pathological roles of PGAM5: An update and Future trend
Weibin He, Wenlong He, Zhongchan Sun, et al.
iScience (2024) Vol. 28, Iss. 2, pp. 111539-111539
Closed Access | Times Cited: 2
Weibin He, Wenlong He, Zhongchan Sun, et al.
iScience (2024) Vol. 28, Iss. 2, pp. 111539-111539
Closed Access | Times Cited: 2
Isolongifolene alleviates liver ischemia/reperfusion injury by regulating AMPK-PGC1α signaling pathway-mediated inflammation, apoptosis, and oxidative stress
Jinjin Li, Jie Li, Hongbo Fang, et al.
International Immunopharmacology (2022) Vol. 113, pp. 109185-109185
Closed Access | Times Cited: 10
Jinjin Li, Jie Li, Hongbo Fang, et al.
International Immunopharmacology (2022) Vol. 113, pp. 109185-109185
Closed Access | Times Cited: 10
Targeting proteostasis of the HEV replicase to combat infection in preclinical models
Fei Zhang, Ling-Dong Xu, Qian Zhang, et al.
Journal of Hepatology (2022) Vol. 78, Iss. 4, pp. 704-716
Closed Access | Times Cited: 9
Fei Zhang, Ling-Dong Xu, Qian Zhang, et al.
Journal of Hepatology (2022) Vol. 78, Iss. 4, pp. 704-716
Closed Access | Times Cited: 9